Ousseny Zerbo to Respiratory Syncytial Virus Infections
This is a "connection" page, showing publications Ousseny Zerbo has written about Respiratory Syncytial Virus Infections.
Connection Strength
0.451
-
Maternal Vaccination vs Nirsevimab Use and Respiratory Syncytial Virus Infection Among Full-Term Infants. JAMA Netw Open. 2026 Oct 01; 9(10):e2636760.
Score: 0.235
-
Effectiveness of Nirsevimab Against RSV and RSV-Related Events in Infants. Pediatrics. 2025 Aug 01; 156(2).
Score: 0.217